Lab tests suggest a strain of the flu virus circulating this season may not be "well-recognized" by the flu vaccine.

Texas is facing its largest measles outbreak in nearly 30 years, with 124 confirmed cases as of February 25, 2025. The outbreak, which started in late January, has been most severe in Gaines County, where 80 cases have been recorded.

In a small study, Yale researchers have found "differences in immune profiles" among those who have rare reaction to the Covid vaccine.

Measles is a highly contagious airborne disease caused by a virus, and can be severe or even fatal. According to the U.S. Centers for Disease Control and Prevention (CDC), the best way to protect yourself against measles is to get vaccinated. Here, TIME answers all your questions about the vaccine.

Check state vaccine registries. Some states and major cities have vaccine databases, though they may be incomplete. Contact past providers. Past doctors, schools, universities and even employers like the military may have vaccine documentation.

COVID-19 vaccines target emerging variants, offering improved protection. Learn about their effectiveness, timing, and safety.

As of Feb. 20, there were a total of 93 measles cases reported in eight states: Alaska, California, Georgia, New Jersey, New Mexico, New York, Rhode Island and Texas, according to the Centers for Disease Control and Prevention. For comparison, 285 cases were reported in the U.S. in 2024.

WASHINGTON (TNND) — Could a bird flu vaccine help lower the price of eggs? According to The National Chicken Council, egg-laying hens account for over 77% of the poultry affected by the virus. But experts say it's not that simple.

Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer recurring in patients who initially respond.

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study co-author Dr. Vinod Balachandran talks about the impact on future cancer care.

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage pancreatic cancer patients.